{
  "docId": "019de075-242a-7291-8f16-5f142d7cb798",
  "docSlug": "c8e6c54234adac3c3fb2311a09419808",
  "documentTitle": "Freeman Capital Management | Activist Presentation Deck | 15 slides",
  "authorId": "freeman-capital-management",
  "authorName": "Freeman Capital Management",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 15,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "Uses a list of arrows to highlight specific failures or admissions in the Greenleaf report.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-242a-7291-8f16-5f142d7cb798/9",
  "deckHref": "/decks/019de075-242a-7291-8f16-5f142d7cb798",
  "deckJsonHref": "/decks/019de075-242a-7291-8f16-5f142d7cb798.json",
  "deckAnchorHref": "/decks/019de075-242a-7291-8f16-5f142d7cb798#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.45,
        "w": 0.25,
        "x": 0.7,
        "y": 0.35
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0cd2283a-8a5d-4dff-a6b0-e86c35eca122",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.65,
        "x": 0.05,
        "y": 0.65
      },
      "kind": "list",
      "text": "Greenleaf states that Liechti's published data cannot be used; but did not dispute FCM's plan to use Dr. Liechti's published and unpublished original data owned by MindMed in a clinical study report to show LSD's effectiveness in Phase II to meet FDA's requirement of \"preliminary evidence.\"",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "74151ba8-ec17-42ca-b792-c43200b968af",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.65,
        "x": 0.05,
        "y": 0.3
      },
      "kind": "list",
      "text": "Greenleaf did not talk to FCM or ask for supporting materials which resulted in a seriously deficient report predicated on strawman arguments and misrepresentation of our plans.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a023b8ed-5d51-41d1-bffd-7504065a60a6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.65,
        "x": 0.05,
        "y": 0.8
      },
      "kind": "list",
      "text": "Greenleaf quotes FDA regulations, which supports FCM's approach stating that \"[Phase 3 studies] are performed after preliminary evidence suggesting effectiveness of the drug has been obtained in Phase 2.\" Dr. Liechti's randomized Phase II studies satisfy this requirement as FCM has stated.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cd653249-818c-4186-a1e1-fbced8706080",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.65,
        "x": 0.05,
        "y": 0.4
      },
      "kind": "list",
      "text": "Greenleaf did not dispute FCM's analysis of each CNS drug approved in the last decade which found that none of those drugs have followed the long, expensive, and tortuous path to drug approval as the plan initiated by MindMed for LSD.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d29d2506-4e28-4e5d-b96a-1eb55258f52f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.65,
        "x": 0.05,
        "y": 0.55
      },
      "kind": "list",
      "text": "Greenleaf does not deny the ability of MindMed to execute FCM's plan with the FDA nor does Greenleaf say it believes MindMed's current path is the best way forward.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dc3d295f-d7c6-4968-8013-89318bb74bb0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.05,
        "y": 0.18
      },
      "kind": "paragraph",
      "text": "MindMed hired a paid consultant Greenleaf to justify its current FDA strategy. Greenleaf's report is supported based on the facts MindMed provided to them.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c7fc636d-1cdb-4a76-82b9-9875cff868d9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.05,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Company SEC Filings, Greenleaf Report. See [3].",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2e2d6a62-021f-4bb8-be79-ec33db295f97",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.5,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "MM-120: Greenleaf Report",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6d5d2788-49a5-4cec-9543-fb0aba2c8deb",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 12,
      "from": 3,
      "beatId": "898b55c8-786a-402d-af69-12e8fbcb4368",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Monster (ISS and MindMed's flaws)",
      "beatSlug": "overcoming-monster-the-monster",
      "evidence": "Slides 3-12 expose contradictions and misleading statements by ISS and MindMed.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Hook",
      "parentBeatSlug": "hook"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}